Skip to Main Content

Author Details

Erik P Sulman
NYU Grossman School of Medicine
1995
199
59
PMIDPaper TitleJournal TitlePublished Year
38048045Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.Clin Cancer Res2024
37581437Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.Neurosurgery2024
38048045Evaluation of the SSTR2-targeted Radiopharmaceutical 177Lu-DOTATATE and SSTR2-specific 68Ga-DOTATATE PET as Imaging Biomarker in Patients with Intracranial Meningioma.Clin Cancer Res2024
37581437Long-term Survival From Breast Cancer Brain Metastases in the Era of Modern Systemic Therapies.Neurosurgery2024
36733357Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021.Front Oncol2023
35849035Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.Neuro Oncol2023
37746263Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology.Front Oncol2023
37476329Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.Neurooncol Adv2023
37082446Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.Front Neurol2023
37326435Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy.Neurosurgery2023
37255296Causes of Death in Patients With Brain Metastases.Neurosurgery2023
36733357Editorial: Insights in neuro-oncology and neurosurgical oncology: 2021.Front Oncol2023
36722962Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era.Neurosurgery2023
37746263Editorial: 365 days of progress in neuro-oncology and neurosurgical oncology.Front Oncol2023
35849035Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.Neuro Oncol2023
37326435Low-Dose Radiosurgery for Brain Metastases in the Era of Modern Systemic Therapy.Neurosurgery2023
37255296Causes of Death in Patients With Brain Metastases.Neurosurgery2023
37082446Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.Front Neurol2023
37476329Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.Neurooncol Adv2023
36722962Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era.Neurosurgery2023
34711456Update on Radiation Therapy for Central Nervous System Tumors.Hematol Oncol Clin North Am2022
35973088Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery.Neurosurgery2022
35906213DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas.Nat Commun2022
36299794Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.Neurooncol Adv2022
35814854Risk of Second Primary Neoplasms of the Central Nervous System.Adv Radiat Oncol2022
35561283Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.J Clin Oncol2022
36202798Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma.Cell Discov2022
36059614PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.Front Oncol2022
35665462Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?J Neurooncol2022
36382106Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma.Neurooncol Adv2022
34987156Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.Nat Commun2022
34561269Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.Clin Cancer Res2022
34711456Update on Radiation Therapy for Central Nervous System Tumors.Hematol Oncol Clin North Am2022
34817796Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.J Neurooncol2022
34932393Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.J Clin Oncol2022
35665462Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era?J Neurooncol2022
35814854Risk of Second Primary Neoplasms of the Central Nervous System.Adv Radiat Oncol2022
35561283Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.J Clin Oncol2022
35973088Modern Hearing Preservation Outcomes After Vestibular Schwannoma Stereotactic Radiosurgery.Neurosurgery2022
35906213DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas.Nat Commun2022
36202798Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAF<sup>V600E</sup> inhibition resistance in melanoma.Cell Discov2022
36059614PDPN marks a subset of aggressive and radiation-resistant glioblastoma cells.Front Oncol2022
36382106Association of hyperglycemia and molecular subclass on survival in IDH-wildtype glioblastoma.Neurooncol Adv2022
36299794Germline polymorphisms in <i>MGMT</i> associated with temozolomide-related myelotoxicity risk in patients with glioblastoma treated on NRG Oncology/RTOG 0825.Neurooncol Adv2022
34932393Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.J Clin Oncol2022
34987156Author Correction: Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.Nat Commun2022
34817796Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.J Neurooncol2022
34561269Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.Clin Cancer Res2022
32750703Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.Neuro Oncol2021
33539787PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells.Mol Cell2021
  • 1 - 50 of 398

Recommended Authors

David R Raleigh
University of California san francisco
Career Start Year 2010
Number of shared co-authors 14
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year 2010
Number of shared co-authors 20
Claudia C Faria
Hospital de Santa Maria, Centro Hospitalar Universitario Lisboa Norte (CHULN)
Career Start Year 2008
Number of shared co-authors 22
Matthew D Wood
Oregon Health & Science University
Career Start Year 2007
Number of shared co-authors 12
Nancy Ann Oberheim Bush
University of California san francisco
Career Start Year 2005
Number of shared co-authors 12
Adam M Sonabend
Northwestern University
Career Start Year 2005
Number of shared co-authors 32
Sabine Mueller
University Children's Hospital Zurich
Career Start Year 2005
Number of shared co-authors 21
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year 2004
Number of shared co-authors 5
Analiz Rodriguez
University of Arkansas for Medical Sciences
Career Start Year 2004
Number of shared co-authors 20
David A Solomon
University of California san francisco
Career Start Year 2003
Number of shared co-authors 21
Martin Glas
University Hospital Essen
Career Start Year 2002
Number of shared co-authors 10
Sheila K Singh
McMaster University
Career Start Year 2001
Number of shared co-authors 8
Andrew P Morokoff
Clinical Sciences Building, The University of Melbourne, The Royal Melbourne Hospital
Career Start Year 2001
Number of shared co-authors 0
Mariza Daras
University of California san francisco
Career Start Year 2001
Number of shared co-authors 23
Brent A Orr
St. Jude Children's Research Hospital
Career Start Year 2000
Number of shared co-authors 18
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 27
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 26
Pim J French
Erasmus MC Cancer Institute
Career Start Year 1995
Number of shared co-authors 35
Kevin Camphausen
National Cancer Institute
Career Start Year 1994
Number of shared co-authors 8
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 24
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year 1992
Number of shared co-authors 32
Richard J Gilbertson
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 26
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 12
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 28
Johan M Kros
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 29
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 12
Guido Reifenberger
Heinrich Heine University
Career Start Year 1987
Number of shared co-authors 36
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 30
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 41
Cynthia Hawkins
The Hospital for Sick Children
Career Start Year 1980
Number of shared co-authors 34

Collaborators

Frederick F Lang
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 33
Kenneth Aldape
National Cancer Institute
Co-authored papers 31
Ravesanker Ezhilarasan
Co-authored papers 22
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Co-authored papers 20
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 18
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 16
Krishna P Bhat
Department of Neurosurgery at the University of Texas MD Anderson Cancer Center
Co-authored papers 16
John F de Groot
Co-authored papers 16
Gregory N Fuller
MD Anderson Cancer Center
Co-authored papers 16
Howard Colman
Huntsman Cancer Institute, University of Utah
Co-authored papers 15
Amy B Heimberger
Northwestern University Feinberg School of Medicine
Co-authored papers 13
Jaclyn A Biegel
Co-authored papers 11
Ganesh Rao
The University of Texas M.D. Anderson Cancer Center
Co-authored papers 10
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 9
Jason T Huse
Co-authored papers 9
Siyuan Zheng
Greehey Children's Cancer Research Institute
Co-authored papers 9
Dimpy Koul
The University of Texas MD Anderson Cancer Center
Co-authored papers 8
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
Minesh P Mehta
Co-authored papers 7
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Co-authored papers 6
Raymond Sawaya
The University of Texas M.D. Anderson Cancer Center, American University of Beirut
Co-authored papers 6
Rivka R Colen
Co-authored papers 6
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Co-authored papers 5
Michael D Hogarty
Co-authored papers 5
??kos V??gv??ri
Karolinska Institutet
Co-authored papers 5
Gelareh Zadeh
University of Toronto
Co-authored papers 5
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Co-authored papers 5
Michael A Vogelbaum
Moffit Cancer Center
Co-authored papers 5
Carol L Nilsson
Lund University
Co-authored papers 5
Gy??rgy Marko-Varga
Clinical Protein Science & Imaging, Biomedical Centre, Lund University
Co-authored papers 5
Release 1.2